History of Present Illness:  39F with h/o polysubstance abuse was found at home by sisters with after suicide attempt with overdose of with unknown amt of tylenol and etoh at approx 1PM.
Intubated and sedated, NG tube placed, given 50mg charcoal, 9200mg NAC loading dose.
Per, sister has been having problems with boyfriend recently, pt left suicide note and left phone calls on sister's voice mail regarding overdose.
Past Medical History: h/o esophageal atresia as child requiring surgery at birth  Social History: drinks 1/4 vodka daily for several years worse over the past [**12-31**] yrs.
+crack/coccaine, [**11-29**] pack smoking for >2 yrs.
vitamin B12 481 .
CXR 12/44/06: Endotracheal tube and nasogastric tube in standard positions.
Brief Hospital Course: A/P: 39 yo woman without significant PMH s/p tylenol overdose as suicide attempt.
1 TYLENOL OVERDOSE:  Tylenol level at OSH on presentation (about 4 hours after ingestion) was 160.
She received a loading dose of 9200mg PO at OSH.
She was seen and evaluated by psychiatry here who feel that she requires inpatient psychiatric treatment on discharge.
She di not require any treatment as she demonstarted no sighs of withdrawl while here.
She should continue thiamine, folate, multivitamin supplements.
4 LEUKOCYTOSIS: slightly elevated WBC count noted on HD 2 (11.3) without signs of infection, which supsequently fell and remained normal.
5 Tobacco use: she was maintained on 14mcg daily nicotine patch while in house.
Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Hexavitamin     Tablet Sig: One (1) Cap PO DAILY (Daily).
Nicotine 21 mg/24 hr Patch 24HR Sig: One (1) Patch 24HR Transdermal DAILY (Daily).
Lorazepam 0.5 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed for CIWA>10 for 2 days: Please continue to assess per CIWA scale every four hours for withdrawl from alcohol and administer lorazepam as needed for CIWA >10.
Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Discharge Instructions: Please take all medications as prescribed.
